» Articles » PMID: 26693644

Non-random Fragmentation Patterns in Circulating Cell-free DNA Reflect Epigenetic Regulation

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2015 Dec 24
PMID 26693644
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The assessment of cell-free circulating DNA fragments, also known as a "liquid biopsy" of the patient's plasma, is an important source for the discovery and subsequent non-invasive monitoring of cancer and other pathological conditions. Although the nucleosome-guided fragmentation patterns of cell-free DNA (cfDNA) have not yet been studied in detail, non-random representation of cfDNA sequencies may reflect chromatin features in the tissue of origin at gene-regulation level.

Results: In this study, we investigated the association between epigenetic landscapes of human tissues evident in the patterns of cfDNA in plasma by deep sequencing of human cfDNA samples. We have demonstrated that baseline characteristics of cfDNA fragmentation pattern are in concordance with the ones corresponding to cell lines-derived. To identify the loci differentially represented in cfDNA fragment, we mapped the transcription start sites within the sequenced cfDNA fragments and tested for association of these genomic coordinates with the relative strength and the patterns of gene expressions. Preselected sets of house-keeping and tissue specific genes were used as models for actively expressed and silenced genes. Developed measure of gene regulation was able to differentiate these two sets based on sequencing coverage near gene transcription start site.

Conclusion: Experimental outcomes suggest that cfDNA retains characteristics previously noted in genome-wide analysis of chromatin structure, in particular, in MNase-seq assays. Thus far the analysis of the DNA fragmentation pattern may aid further developing of cfDNA based biomarkers for a variety of human conditions.

Citing Articles

Application of plasma cell-free DNA in screening of advanced colorectal adenoma.

Chen B, Ng H, Liu Y, Zhang W, Wang G Eur J Med Res. 2025; 30(1):136.

PMID: 40001191 PMC: 11853481. DOI: 10.1186/s40001-025-02313-z.


Circulating Cell-Free DNA in Metabolic Diseases.

Pollastri A, Kovacs P, Keller M J Endocr Soc. 2025; 9(2):bvaf006.

PMID: 39850787 PMC: 11756337. DOI: 10.1210/jendso/bvaf006.


The Role of Breast Milk Cell-Free DNA in the Regulation of the Neonatal Immune Response.

Rezai T, Fell-Hakai S, Guleria S, Toldi G Nutrients. 2025; 16(24.

PMID: 39770994 PMC: 11678730. DOI: 10.3390/nu16244373.


OCRClassifier: integrating statistical control chart into machine learning framework for better detecting open chromatin regions.

Lai X, Liu M, Liu Y, Zhu X, Wang J Front Genet. 2024; 15:1400228.

PMID: 39698466 PMC: 11652186. DOI: 10.3389/fgene.2024.1400228.


Expanded knowledge of cell-free DNA biology: potential to broaden the clinical utility.

Che H, Stanley K, Jatsenko T, Thienpont B, Vermeesch J Extracell Vesicles Circ Nucl Acids. 2024; 3(3):216-234.

PMID: 39697489 PMC: 11648412. DOI: 10.20517/evcna.2022.21.


References
1.
Hodges E, Xuan Z, Balija V, Kramer M, Molla M, Smith S . Genome-wide in situ exon capture for selective resequencing. Nat Genet. 2007; 39(12):1522-7. DOI: 10.1038/ng.2007.42. View

2.
Wang J, Liu S, Fu W . Nucleosome Positioning with Set of Key Positions and Nucleosome Affinity. Open Biomed Eng J. 2015; 8:166-70. PMC: 4549903. DOI: 10.2174/1874120701408010166. View

3.
Delgado P, Alves B, Gehrke F, Kuniyoshi R, Wroclavski M, Del Giglio A . Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumour Biol. 2012; 34(2):983-6. DOI: 10.1007/s13277-012-0634-6. View

4.
Umetani N, Giuliano A, Hiramatsu S, Amersi F, Nakagawa T, Martino S . Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006; 24(26):4270-6. DOI: 10.1200/JCO.2006.05.9493. View

5.
Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z . Measurement of apoptosis by DNA fragmentation. Methods Mol Biol. 2004; 282:1-17. DOI: 10.1385/1-59259-812-9:001. View